Clinical trials
Completed Phase 2 trials in Thailand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
311 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 9 |
| 2005 | 13 |
| 2006 | 12 |
| 2007 | 20 |
| 2008 | 24 |
| 2009 | 11 |
| 2010 | 18 |
| 2011 | 17 |
| 2012 | 12 |
| 2013 | 21 |
| 2014 | 18 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 14 |
| 2018 | 16 |
| 2019 | 16 |
| 2020 | 12 |
| 2021 | 13 |
| 2022 | 13 |
| 2023 | 12 |
| 2024 | 9 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 311 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 40 |
| GlaxoSmithKline | 21 |
| Hoffmann-La Roche | 20 |
| The HIV Netherlands Australia Thailand Research Collaboration | 16 |
| Mahidol University | 14 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 13 |
| Boehringer Ingelheim | 10 |
| Thammasat University | 8 |
| Merck Sharp & Dohme LLC | 7 |
| Novo Nordisk A/S | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 23 |
| Breast Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Hepatitis B, Chronic | 10 |
| Hepatitis B | 9 |
| Influenza, Human | 9 |
| Recurrence | 8 |
| Thalassemia | 8 |
| beta-Thalassemia | 8 |
| Asthma | 7 |
Trials
Showing 1 to 25 of 311. Each trial links to its page on Pharma Observatory.
211 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.